Literature DB >> 19500827

Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations.

Anita H J van den Biggelaar1, Susan L Prescott, Marjut Roponen, Marie A Nadal-Sims, Catherine J Devitt, Suparat Phuanukoonnon, William Pomat, Meri K Tulic, Deborah Lehmann, Peter M Siba, Peter C Richmond, Patrick G Holt.   

Abstract

BACKGROUND: The protective effect of Mycobacterium bovis BCG vaccination against infection and atopy varies between populations.
OBJECTIVE: To identify differences in neonatal responses to BCG between diverse populations and study longitudinal associations with memory T-cell responses.
METHODS: Cord blood mononuclear cells were collected from Papua New Guinean (PNG) and Western Australian (WA) newborns. Toll-like receptor (TLR)-2, TLR4, and TLR9 mRNA expression and in vitro BCG-stimulated (+/-IFN-gamma priming) innate cytokine responses were compared. When PNG infants were 3 months old, PBMCs were stimulated in vitro with Mycobacterium-purified protein derivative (PPD) to determine memory T-cell responses.
RESULTS: BCG-induced IL-10 and IFN-gamma responses were significantly higher in cord blood mononuclear cells of PNG newborns, and TLR2 and TLR9 expression was significantly higher and TLR4 expression lower compared with WA newborns. High neonatal IL-10 and low IFN-gamma responses to BCG were found to promote the development of PPD-memory T(H)2 responses in infancy, whereas neonatal BCG-TNFalpha responses inhibited the development of PPD-IL 10 responses. When primed with IFN-gamma, BCG-induced TNF-alpha, IL-12p70, and in particular IFN-gamma responses were enhanced to a significantly higher extent in WA than in PNG newborns. In response to IFN-gamma priming and BCG stimulation, natural killer cells of WA newborns produced IFN-gamma, whereas natural killer cells of PNG newborns contributed only indirectly to this response.
CONCLUSION: Neonatal BCG-related innate immune responses control the differentiation of T(H) memory responses and vary between populations. This may explain differences in the effects of BCG vaccination between populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500827     DOI: 10.1016/j.jaci.2009.03.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  22 in total

1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries.

Authors:  A H J van den Biggelaar; P G Holt
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Innate Immune Responses and Gut Microbiomes Distinguish HIV-Exposed from HIV-Unexposed Children in a Population-Specific Manner.

Authors:  Nelly Amenyogbe; Pedro Dimitriu; Patricia Cho; Candice Ruck; Edgardo S Fortuno; Bing Cai; Ariane Alimenti; Hélène C F Côté; Evelyn J Maan; Amy L Slogrove; Monika Esser; Arnaud Marchant; Tessa Goetghebuer; Casey P Shannon; Scott J Tebbutt; Tobias R Kollmann; William W Mohn; Kinga K Smolen
Journal:  J Immunol       Date:  2020-10-16       Impact factor: 5.422

3.  Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus.

Authors:  Andrew J Currie; Samantha Curtis; Tobias Strunk; Karen Riley; Khemanganee Liyanage; Susan Prescott; Dorota Doherty; Karen Simmer; Peter Richmond; David Burgner
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

4.  Association of in utero sensitization to Schistosoma haematobium with enhanced cord blood IgE and increased frequencies of CD5- B cells in African newborns.

Authors:  Larsen S Seydel; Annika Petelski; Govert J van Dam; Desiree van der Kleij; Yvonne C M Kruize-Hoeksma; Adrian J F Luty; Maria Yazdanbakhsh; Peter G Kremsner
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 5.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

6.  Maturation of innate responses to mycobacteria over the first nine months of life.

Authors:  Muki S Shey; Elisa Nemes; Wendy Whatney; Marwou de Kock; Hadn Africa; Charlene Barnard; Michele van Rooyen; Lynnett Stone; Catherine Riou; Tobias Kollmann; Thomas R Hawn; Thomas J Scriba; Willem A Hanekom
Journal:  J Immunol       Date:  2014-04-14       Impact factor: 5.422

7.  Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype.

Authors:  Damien Portevin; Laura E Via; Seokyong Eum; Douglas Young
Journal:  Cell Microbiol       Date:  2012-07-30       Impact factor: 3.715

8.  Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway.

Authors:  Seema M Thayil; Ya-Chi Ho; Robert C Bollinger; Joel N Blankson; Robert F Siliciano; Petros C Karakousis; Kathleen R Page
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 9.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31

10.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.